Regulation by endogenous interleukin-10 of the expression of nitric oxide synthase induced after ligation of CD23 in human monocytes

Cytokine

Volumn 10, Issue 9, 1998, Pages 680-689

  Dugas, Nathalie ^a   Palacios Calender, Miriam ^b   Dugas, Bernard ^d   Riveros Moreno, Valentina ^e   Delfraissy, Jean François ^a   Kolb, Jean Pierre ^c   Moncada, Salvador ^b  

^a Neuroradiology   (France)

^b Cruciform Project   (United Kingdom)

^c INSTITUT CURIE   (France)

^d SAINT JOSEPH HOSPITAL   (France)

^e NONE

Author keywords

CD23; Human macrophages; IL 10; NO

Indexed keywords

CD23 ANTIGEN; INTERLEUKIN 10; MESSENGER RNA; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; FEEDBACK SYSTEM; HUMAN; HUMAN CELL; MACROPHAGE; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032169015     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0352     Document Type: Article

References (59)

1. 1. Kinter C, Sugden B (1981) Identification of antigenic determinants unique to the surface of cells transformed by Epstein-Barr virus. Nature 294:458-461.
2. 2. Delespesse G, Suter U, Mossalayi D, Bettler B, Sarfati M, Hofstetter H, Kilcherr E, Debré P, Dalloul A (1991) Expression, structure and function of the CD23 antigen. Adv Immunol 49:149-191.
3. 3. Borish L, Mascali JJ, Rosenwasser LJ (1991) IgE-dependent monokine production by human peripheral blood mononuclear phagocytes. J Immunol 146:63-68.
4. 4. Gordon J (1991) CD23: a novel disease marker with a split personality. Clin Exp Immunol 86:356-361.
5. 5. Paul-Eugène N, Kolb JP, Abadie A, Gordon J, Delespesse G, Sarfati M, Mencia-Huerta JM, Braquet P, Dugas B (1992) Ligation of CD23 triggers cAMP generation and release of inflammatory mediator in human monocytes. J Immunol 149: 3066-3071.
6. 6. Ouaaz F (1995) Nitric oxide in human haematopoiesis. Res Immunol 146:678-681.
7. 7. Ouaaz F, Sola B, Issaly F, Kolb JP, Davi F, Mentz F, Arock M, Paul-Eugène N, Körner M, Dugas B, Debré P, Mosslayi MD (1994) Growth arrest and terminal differentiation of leukemic myelomonocytic cells induced through ligation of surface CD23 antigen. Blood 84:3095-3104.
8. 8. Vercelli D, Jabara HH, Lee B-W, Woodland N, Geha RS, Leung DYM (1988) Human recombinant interleukin 4 induces FcεR2/CD23 on normal human monocytes. J Exp Med 167: 1406-1411.
9. 9. Vouldoukis I, Riveros-Moreno V, Dugas B, Ouaaz F, Debré P, Moncada S, Mossalayi DM (1995) The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FcεRII/CD23 surface antigen. Proc Natl Acad Sci USA 92:7804-7808.
10. 10. Paul-Eugène N, Kolb JP, Sarfati M, Arock M, Ouaaz F, Debré P, Mossalayi MD Dugas B (1995) Ligation of CD23 activates soluble guanylate cyclase in human monocytes via an L-arginine-dependent mechanism. J Leukoc Biol 57:160-167.
11. 11. Riveros-Moreno V, Palacios M, Rodrigo J, Martinez-Murillo R, Moncada S (1995) Characterisation of inducible nitric oxide synthase in human monocytes/macrophages after ligation of the CD23 receptor. In Moncada S, Stamler J, Gross S, Higgs EA, (eds) Biology of Nitric oxide. Part 5. Portland Press, p. 160.
12. 12. Vouldoukis I, Mazier D, Debré P, Mossalayi MD (1995) Nitric oxide and infectious diseases. Res Immunol 146:689-692.
13. 13. Albina JE (1995) On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukoc Biol 58:643-649.
14. 14. Weinberg JB, Misukonis, Shami PJ, Mason SN, Sauls WA, Dittman WA, Wood ER, Smith GK, McDonald B, Bachus KE, Haney AF, Granger DL (1995) Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86:1184-1195.
15. 15. Schneemann M, Schoedon G, Hofer S, Blau N, Guerrero L, Schaffner A (1993) Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J Infect Dis 167:1358-1363.
16. 16. Martin JHJ, Edwards SW (1993) Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture: reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor killing. J Immunol 150:3478-3486.
17. 17. Kolb JP, Paul-Eugène N, Damais C, Yamaoka K, Drapier JC, Dugas B (1994) IL-4 stimulates cGMP production by IFN-γ-activated human monocytes. Involvement of the nitric oxide synthase pathway. J Biol Chem 269:9811-9816.
18. 18. Reiling N, Ulmer AJ, Duchrow M, Ernst M, Flad HD, Hauschildt S (1994) Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol 24:1941-1944.
19. 19. De Maria R, Cifone MG, Trotta R, Rippo MR, Festuccia C, Santoni A, Testi R (1994) Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex of signal transducing receptors. J Exp Med 181:735-745.
20. 20. Pietraforte D, Tritarelli E, Testa U, Minetti M (1994) gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J Leukoc Biol 55: 175-182.
21. 21. Bukrinsky MI, Nottet HSLM, Schmidtmayerova H, Dubrovsky L, Flanagan CR, Mullins ME, Lipton SA, Gendeleman HE (1995) Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 191:735-745.
22. 22. Moilanen E, Moilanen T, Knowles R, Charles I, Kadoya Y, AlSaffar N, Revell PA, Moncada S (1997) Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am J Pathol 150:881-887.
23. 23. Dugas B, Mossalayi DM, Damais C, Kolb JP (1995) Nitric oxide production by human monocytes/macrophages. Evidence for a role of CD23. Immunol Today 16:574-580.
24. 24. Dugas N, Delfraissy JF, Tardieu M (1995) Immune regulatory role of nitric oxide within the central nervous system. Res Immunol 146:707-710.
25. 25. Dugas N, Vouldoukis I, Bécherel P, Arock M, Debré P, Tardieu M, Mossalayi MD, Delfraissy JF, Kolb JP, Dugas B (1996) Triggering of CD23b antigen by anti-CD23 monoclonal antibodies induces interleukin-10 production by human macrophages. Eur J Immunol 26:1394-1398.
26. 26. Cunha FQ, Moncada S, Liew FY (1992) Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun 182:1155-1159.
27. 27. Aubry JP, Dugas N, Lecoanet-Henchoz S, Ouaaz F, Zhao H, Delfraissy JF, Graber P, Kolb JP, Dugas B, Bonnefoy JY (1997) The 25-kDa soluble CD23 activates type III constitutive nitric oxide-synthase activity via CD11b and CD11c expressed by human monocytes. J Immunol 159:614-622.
28. 28. Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142.
29. 29. Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064.
30. 30. Alonso A, Carvalho J, Alonso-Torre SR, Nunez L, Bosca L, Sanchez Crespo M (1995) Nitric oxide synthesis in rat peritoneal macrophages is induced by IgE/DNP complexes and cyclic AMP analogues. Evidence in favour of a common signaling mechanism. J Immunol 154:6475-6483.
31. 31. Bukrinsky M, Schmidtmayerova H, Zybarth G, Dubrovsky L, Sherry B, Enikolopov G (1996) A critical role of nitric oxide in HIV-1-induced hyperresponsiveness of human monocytes. Mol Med 2:460-468.
32. 32. Ouaaz F, Ruscetti FW, Dugas B, Mikovitz J, Agut M, Debré P, Mossalayi MD (1996) Effects of IgE immune complexes on HIV-1 replication and cell death in infected U1 monocytes: involvement of CD23/FcεRII mediated nitric oxide and cyclic AMP pathways. Mol Med 2:38-49.
33. 33. Albina JE, Cui S, Mateo RB, Reichner JS (1993) Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 150:5080-5085.
34. 34. Schneemann M, Schoedon G, Frei K, Schaffner A (1993) Immunovascular communication: activation and deactivation of murine endothelial cell nitric oxide synthase by cytokines. Immunol Lett 35:159-162.
35. 35. LeClaire RD, Kell WM, Sadik RA, Downs MB, Parker GW (1995) Regulation of staphylococcal enterotoxin-B-elicited nitric oxide production by endothelial cells. Infect Immun 63:539-546.
36. 36. Marshall BG, Chambers MA, Wangoo A, Shaw RJ, Young DB (1997) Production of tumor necrosis factor and nitric oxide by macrophages infected with live and dead mycobacteria and their suppression by an interleukin-10-secreting recombinant. Infect Immun 65:1931-1935.
37. 37. Cenci E, Romani L, Mencacci A, Spaccapelo R, Schiaffella E, Puccetti P, Bistoni F (1993) Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 23:1034-1038.
38. 38. Gazzinelli RT, Oswald IP, Hieny S, James SL, Sher A (1992) The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur J Immunol 22:2501-2506.
39. 39. Oswald IP, Wynn TA, Sher A, James SL (1992) Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc Natl Acad Sci USA 89:8676-8680.
40. 40. Corradin SB, Fasel N, Buchmuller-Rouiller Y, Ransijn A, Smith J, Mauel J (1993) Induction of macrophage nitric oxide production by interferon-gamma and tumor necrosis factor-alpha is enhanced by interleukin-10. Eur J Immunol 23:2045-2048.
41. 41. Chesrown SE, Monnier J, Visner G, Nick HS (1994) Regulation of inducible nitric oxide synthase mRNA levels by LPS, IFN-γ, TGF-β and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem Biophys Res Commun 200: 126-134.
42. 42. Loftis LL, Meals EA, English BK (1997) Differential effects of pentoxifylline and interleukin-10 on production of tumor necrosis factor and inducible nitric oxide synthase by murine macrophages. J Infect Dis 175:1008-1011.
43. 43. Vouldoukis I, Becherel PA, Riveros-Moreno V, Arock M, da Silva O, Debré P, Mazier D, Mossalayi MD (1997) Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur J Immunol 27:860-865.
44. 44. Bécherel PA, Le Goff L, Ktorza S, Ouaaz F, Mencia-Huerta JM, Dugas B, Debré P, Mossalayi MD, Arock M (1995) Interleukin-10 inhibits IgE-mediated nitric oxide synthase induction and cytokine synthesis in normal human keratinocytes. Eur J Immunol 25: 2992-2995.
45. 45. Wang PW, Wu P, Siegel MI, Egan RW, Billah MM (1995) Interleukin (IL)-10 inhibits nuclear factor κB (NF-κB) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J Biol Chem 270:9558-9563.
46. 46. Spittler A, Schiller C, Willheim M, Tempfer C, Winkler S, Boltz-Nitulescu G (1995) Il-10 augments CD23 expression on U937 cells and down-regulates IL-4-driven CD23 expression on cultured human blood monocytes: effects of IL-10 and other cytokines on cell phenotype and phagocytosis. Immunology 85:311-317.
47. 47. Napolitano LM, Campbell C (1994) Nitric oxide inhibition normalizes splenocyte interleukin-10 synthesis in murine thermal injury. Arch Surgery 129:1276-1282.
48. 48. Ianaro A, O'Donnell CA, Di Rosa M, Liew FY (1994) A nitric oxide synthase inhibitor reduces inflammation, down regulates inflammatory cytokines and enhances interleukin-10 production in carrageenin-induced oedema in mice. Immunology 82:370-375.
49. 49. Frei K, Nadal D, Pfister HW, Fontana A (1993) Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10. J Exp Med 178:1255-1261.
50. 50. Rogy MA, Auffenberg T, Espat NJ, Philip R, Remick D, Wollenberg GK, Copeland EM 3rd, Moldawer LL (1995) Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses. J Exp Med 181:2289-2293.
51. 51. Perretti M, Szabo C, Thiemermann C (1995) Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. British J Pharmacol 116:2251-2257.
52. 52. Berg DJ, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N, Grunig G, Rennick D (1995) Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Inv 96:2339-2347.
53. 53. Kolb H, Worz-Pagenstert U, Kleemann R, Rothe H, Rowsell P, Scott FW (1996) Cytokine gene expression in the BB rat pancreas: natural course and impact of bacterial vaccines. Diabetologia 39:1448-1454.
54. 54. Nüssler AK, Billiar TR (1993) Inflammation, immunoregulation and inducible nitric oxide synthase. J Leukoc Biol 54:171-178.
55. 55. Stamler J (1994) Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 78:931-936.
56. 56. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624.
57. 57. Moncada S, Higgs A (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9:1319-1330.
58. 58. Rector E, Nakajima T, Rocha C, Duncan D, Lestourgeon D, Mitchell RS, Fischer J, Sehon A, Delespesse G (1985) Detection and characterization of monoclonal antibodies to IgE receptors on human hymphocytes by flow cytometry. Immunology 55: 481-486.
59. 59. Paul-Eugène N, Dugas B, Picquot S, Lagente V, Mencia-Huerta JM, Braquet P (1990) Influence of interleukin-4 and platelet-activating factor on the expression of FcεRII/CD23 expression on human monocytes. J Lipid Med 2:95-99.